How do patterns of progression influence treatment selection after chemohormonal therapy in patients with metastatic hormone sensitive prostate cancer?

被引：1
|
作者：
De La Rosa, Carlos Aguado
Carbonero, Iciar Garcia
De Velasco, Guillermo
Alonso, Teresa
Villalobos, Maria L.
Garrido, Maria
Gallegos, Isabel
Martin, Almudena
Pinto, Alvaro
Alonso, Constanza Maximiano
Rodriguez-Moreno, J. F.
Rodriguez, Laura
Sereno, Maria
Perezagua, Carmen
Marrupe, David
Riquelme, Alejandro
Cassinello, Javier
Grande, Enrique
Puente, Javier
Gajate, Pablo
机构：
[1] Hosp Univ Clin San Carlos, Madrid, Spain
[2] Hosp Virgen Salud, Toledo, Spain
[3] Hosp Univ 12 Octubre, Madrid, Spain
[4] Hosp Univ Ramon y Cajal, Madrid, Spain
[5] Hosp Univ Principe Asturias, Madrid, Spain
[6] Hosp Univ Severo Ochoa, Madrid, Spain
[7] Hosp Gen Segovia, Segovia, Spain
[8] Hosp Infanta Leonor, Madrid, Spain
[9] Hosp Univ La Paz, Madrid, Spain
[10] Hosp Univ Puerta Hierro, Madrid, Spain
[11] Ctr Integral Oncol Clara Campal, Madrid, Spain
[12] Hosp Univ Fuenlabrada, Fuenlabrada, Spain
[13] Hosp Univ Infanta Sofia, Madrid, Spain
[14] Hosp Univ Henares, Coslada, Spain
[15] Hosp Univ Mostoles, Mostoles, Spain
[16] Hosp Univ Infanta Cristina, Parla, Spain
[17] Hosp Univ Guadalajara, Guadalajara, Spain
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2017年 / 35卷
关键词：
D O I：
10.1200/JCO.2017.35.15_suppl.e16504
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e16504
引用
收藏
页数：5
相关论文
共 50 条
  • [1] The role of chemohormonal therapy in metastatic hormone sensitive prostate cancer
    Kanesvaran, Ravindran
    Lee, Ji Youl
    Chiong, Edmund
    PROSTATE INTERNATIONAL, 2015, 3 : 516 - 517
  • [2] Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer
    Sweeney, Christopher J.
    Chen, Yu-Hui
    Carducci, Michael
    Liu, Glenn
    Jarrard, David F.
    Eisenberger, Mario
    Wong, Yu-Ning
    Hahn, Noah
    Kohli, Manish
    Cooney, Matthew M.
    Dreicer, Robert
    Vogelzang, Nicholas J.
    Picus, Joel
    Shevrin, Daniel
    Hussain, Maha
    Garcia, Jorge A.
    DiPaola, Robert S.
    NEW ENGLAND JOURNAL OF MEDICINE, 2015, 373 (08): : 737 - 746
  • [3] Re: Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer
    Mathieu, Romain
    Shariat, Shahrokh F.
    EUROPEAN UROLOGY, 2016, 69 (04) : 755 - 756
  • [4] Re: Chemohormonal Therapy in Metastatic Hormone-sensitive Prostate Cancer
    de Reijke, Theo
    EUROPEAN UROLOGY, 2016, 69 (01) : 178 - 178
  • [5] Re: Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer
    Murphy, Declan G.
    Zargar, Homayoun
    EUROPEAN UROLOGY, 2016, 69 (03) : 540 - 540
  • [6] Chemohormonal therapy for metastatic hormone-sensitive prostate cancer: An Asian perspective
    Teoh, Jeremy Yuen-Chun
    Ng, Chi-Fai
    Poon, Darren Ming-Chun
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2018, 14 : 5 - 8
  • [7] Chemohormonal Therapy in Hormone-Sensitive Prostate Cancer
    Ciccarese, Chiara
    Santoni, Matteo
    Massari, Francesco
    NEW ENGLAND JOURNAL OF MEDICINE, 2016, 374 (03): : 286 - 286
  • [8] Taxane-based chemohormonal therapy for metastatic hormone-sensitive prostate cancer
    Sathianathen, Niranjan J.
    Philippou, Yiannis A.
    Kuntz, Gretchen M.
    Konety, Badrinath R.
    Gupta, Shilpa
    Lamb, Alastair D.
    Dahm, Philipp
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2018, (10):
  • [9] Targeting Metastatic Hormone Sensitive Prostate Cancer: Chemohormonal Therapy and New Combinatorial Approaches
    Damodaran, Shivashankar
    Lang, Joshua M.
    Jarrard, David F.
    JOURNAL OF UROLOGY, 2019, 201 (05): : 876 - 885
  • [10] Re: Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer Editorial Comment
    Taneja, Samir S.
    JOURNAL OF UROLOGY, 2016, 195 (01): : 94 - 94
12345